Core A: Administrative Core
Core A: Administrative Core
批准号:
9071064
负责人:
James Brugarolas
金额:
$16.33万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-01 至 2021-07-31
关键词:
AdherenceAdvocateAwarenessBasic ScienceBiometryCancer BiologyCancer CenterCancer PatientCaringClinicalClinical ResearchCommon NeoplasmCommunicationComplementComplexCounty HospitalsData AnalyticsDevelopmentDisputesEnsureEpidemiologyEventFacultyFaculty RecruitmentFundingGrantHispanicsHospitalsIncidenceIndividualK-Series Research Career ProgramsLaboratoriesLeadershipMedical centerMissionMonitorOperative Surgical ProceduresPatient advocacyPatientsQualifyingRecording of previous eventsRegulationRenal carcinomaReportingResearchResearch PersonnelResolutionResource AllocationResource SharingRoleScheduleScienceServicesTexasTranslatingTranslational ResearchUnderserved PopulationUniversitiesUniversity HospitalsUrologyWagesWomanbiomedical informaticscareercostdata managementexperienceindexingmedical schoolsmeetingsmemberoutreachprofessorprogramssocialvolunteer
中文摘要
项目总结
英文摘要
Project Summary
This core will provide essential administrative services and support for the UTSW Kidney Cancer SPORE.
The PI, Dr. Brugarolas, is well-suited to provide overall direction, facilitate interactions, provide scientific
leadership, and oversee the fiscal management of this complex grant. His scientific background, history of
participation in many aspects of translational science, and current administrative roles at UTSW (including
Leader of the Kidney Cancer Program (KCP) and member of the scientific leadership of the NCI-designated,
now comprehensive, Simmons Cancer Center) make him well-qualified to serve as overall PI and Core
Director. He is aided by Core A Co-Directors, Dr. Sagalowsky (Professor of Urology and Surgery, and a KCP
Urology co-Leader), and Dr. McKay (KCP Director of Research Administration), and a first-rate administrative
team. An Executive Committee (Project Leaders and Core Directors) provides advice for the planning of
SPORE strategic directions, interactions with departments and administration, faculty recruitment, and
resource allocation. The KCP and SPORE are well-integrated within the Cancer Center and benefit from many
shared resources. Institutional commitment is illustrated by (i) participation in the IAB of outstanding
investigators and institutional leaders, and (ii) a significant financial commitment, including $1,100,000 in
annual direct support for salaries, benefits and operating costs of key investigators and their laboratories, and
recurring annual funds of: $150,000 (to match CEP and DRP), $150,000 (to support the Data Analytics Core),
and $50,000 (discretionary funds). In addition, $1,100,000 in recruitment funds will be made available. The
SPORE includes a dynamic patient advocacy team of engaged individuals who have participated extensively in
the KCP, including fundraising, raising awareness, and social events. Our outstanding EAB includes leaders in
their fields with complementary expertise in clinical/translational research (Arteaga, George, Michaelson,
Nelson, Oh, Ratain, and Shyr), epidemiological research (Heng and Shyr), and basic research (Simon). The
Core A aims are straightforward and should fulfill the objective of organizing a complex network of interactions
involving numerous investigators, staff, cores, and advocates: (1) Oversee and direct all scientific and
administrative aspects of the SPORE including research/data management, fiscal oversight and adherence,
and communication aspects: (a) Oversee and maintain scientific quality and rigor of the SPORE; (b) Record,
monitor, and oversee all budgetary items; (c) Monitor and ensure all aspects of SPORE compliance following
NCI regulations and requirements, and communicate with NCI Program Officer (and other staff) to ensure
compliance with reporting; (d) Schedule and organize all meetings, including meetings with the Advisory
Boards, and Patient Advocates. (2) Oversee and coordinate with the Developmental Research Program and
the Career Enhancement Program to provide fiscal, organizational, and outreach support. (3) Coordinate and
oversee Patient Advocate Program activities. (4) Oversee and facilitate resolution of scientific disputes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dissecting the mechanism of cabozantinib anti-tumor effect in renal cancer
-
批准号:10443836
-
项目类别:
-
资助金额:$22.54万
-
财政年份:2021
-
负责人:James Brugarolas
-
依托单位:
Dissecting the mechanism of cabozantinib anti-tumor effect in renal cancer
-
批准号:10289979
-
项目类别:
-
资助金额:$19.16万
-
财政年份:2021
-
负责人:James Brugarolas
-
依托单位:
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer
-
批准号:9071063
-
项目类别:
-
资助金额:$216.2万
-
财政年份:2016
-
负责人:James Brugarolas
-
依托单位:
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer
-
批准号:9752982
-
项目类别:
-
资助金额:$213.8万
-
财政年份:2016
-
负责人:James Brugarolas
-
依托单位:
Developmental Research Program
-
批准号:10708855
-
项目类别:
-
资助金额:$20.66万
-
财政年份:2016
-
负责人:James Brugarolas
-
依托单位:
University of Texas Southwestern Medical Center SPORE in Kidney Cancer
-
批准号:10706530
-
项目类别:
-
资助金额:$217.34万
-
财政年份:2016
-
负责人:James Brugarolas
-
依托单位:
Project 1: Targeting HIF2 in Renal Cell Carcinoma
-
批准号:10708828
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2016
-
负责人:James Brugarolas
-
依托单位:
Core A: Administrative Core
-
批准号:10708829
-
项目类别:
-
资助金额:$14.59万
-
财政年份:2016
-
负责人:James Brugarolas
-
依托单位:
Developmental Research Program
-
批准号:9071068
-
项目类别:
-
资助金额:$16.85万
-
财政年份:2016
-
负责人:James Brugarolas
-
依托单位:
Evaluation of the BAP1 tumor suppressor gene in renal cell carcinoma
-
批准号:9008030
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2013
-
负责人:James Brugarolas
-
依托单位:
Evaluation of the BAP1 tumor suppressor gene in renal cell carcinoma
-
批准号:8632102
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2013
-
负责人:James Brugarolas
-
依托单位:
Evaluation of the BAP1 tumor suppressor gene in renal cell carcinoma
-
批准号:8777950
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2013
-
负责人:James Brugarolas
-
依托单位:
Evaluation of the BAP1 tumor suppressor gene in renal cell carcinoma
-
批准号:9185277
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2013
-
负责人:James Brugarolas
-
依托单位:
Regulation of the mTOR Pathway by Hypoxia and the REDD1 Protein
-
批准号:8118778
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2008
-
负责人:James Brugarolas
-
依托单位:
Regulation of the mTOR Pathway by Hypoxia and the REDD1 Protein
-
批准号:7581865
-
项目类别:
-
资助金额:$31.93万
-
财政年份:2008
-
负责人:James Brugarolas
-
依托单位:
Regulation of the mTOR Pathway by Hypoxia and the REDD1 Protein
-
批准号:7894594
-
项目类别:
-
资助金额:$32.58万
-
财政年份:2008
-
负责人:James Brugarolas
-
依托单位:
Regulation of the mTOR Pathway by Hypoxia and the REDD1 Protein
-
批准号:7690291
-
项目类别:
-
资助金额:$32.58万
-
财政年份:2008
-
负责人:James Brugarolas
-
依托单位:
Regulation of the mTOR Pathway by Hypoxia and the REDD1 Protein
-
批准号:8304398
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2008
-
负责人:James Brugarolas
-
依托单位:
VEGF regulation by the TSC2 tumor suppressor
-
批准号:7068600
-
项目类别:
-
资助金额:$15.1万
-
财政年份:2005
-
负责人:James Brugarolas
-
依托单位:
VEGF regulation by the TSC2 tumor suppressor
-
批准号:7421034
-
项目类别:
-
资助金额:$17.3万
-
财政年份:2005
-
负责人:James Brugarolas
-
依托单位:
海外基金